Market entry in China and the conditions for competing locally are becoming incrementally harder for foreign medtech innovators seeking to serve fast-growing patient demand in a population of 1.439 billion people (in 2020, sourced from OECD on 6 July 2022).
Foreign companies with mainstream medtech offerings can expect market access in China to become more and more difficult, according to...